Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2030

Conditions
Gastric Cancer
Interventions
BIOLOGICAL

CTL

Mononuclear cells (Dendritic Cell,DC precursor) were isolated from the peripheral blood of gasric cancer by density gradient centrifugation and infected with rAAV/CEA virus.Maturation of the DC was induced by granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-4 (IL-4) and tumor necrosis factor-alpha(TNF-alpha). On day 7, the DCs were collected and mixed with T cells at the ratio of 1 to 20 to induce cytotoxic T lymphocytes (CTL).The cells will be proliferated and infused by intravenous (IV) infusion into the patient.

All Listed Sponsors
lead

The First People's Hospital of Changzhou

OTHER